80 related articles for article (PubMed ID: 24236625)
1. Management options for children with attention-deficit/hyperactivity disorder: a regional perspective on value.
Ollendorf DA; Migliaccio-Walle K; Colby JA; Pearson SD
J Comp Eff Res; 2013 May; 2(3):261-71. PubMed ID: 24236625
[TBL] [Abstract][Full Text] [Related]
2. Management strategies for attention-deficit/hyperactivity disorder: a regional deliberation on the evidence.
Emond SK; Ollendorf DA; Colby JA; Reed SJ; Pearson SD
Postgrad Med; 2012 Sep; 124(5):58-68. PubMed ID: 23095426
[TBL] [Abstract][Full Text] [Related]
3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the evidence on comparative effectiveness and value of management options for treatment-resistant depression.
Emond SK; Ollendorf DA; Colby JA; Reed SJ; Pearson SD
Postgrad Med; 2013 Nov; 125(6):7-16. PubMed ID: 24200756
[TBL] [Abstract][Full Text] [Related]
5. Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid.
Hoagwood KE; Kelleher K; Zima BT; Perrin JM; Bilder S; Crystal S
Health Aff (Millwood); 2016 Jul; 35(7):1266-70. PubMed ID: 27385243
[TBL] [Abstract][Full Text] [Related]
6. Attention-deficit/hyperactivity disorder: identifying high priority future research needs.
Gaynes BN; Christian R; Saavedra LM; Wines R; Jonas DE; Viswanathan M; Ellis AR; Woodell C; Carey TS
J Psychiatr Pract; 2014 Mar; 20(2):104-17. PubMed ID: 24638045
[TBL] [Abstract][Full Text] [Related]
7. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder?
Toomey SL; Finkelstein J; Kuhlthau K
Pediatrics; 2008 Aug; 122(2):368-74. PubMed ID: 18676555
[TBL] [Abstract][Full Text] [Related]
8. Do parent perceptions predict continuity of publicly funded care for attention-deficit/hyperactivity disorder?
Zima BT; Bussing R; Tang L; Zhang L
Pediatrics; 2013 Mar; 131 Suppl 1():S50-9. PubMed ID: 23457150
[TBL] [Abstract][Full Text] [Related]
9. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
10. Interventions for preschool children at high risk for ADHD: a comparative effectiveness review.
Charach A; Carson P; Fox S; Ali MU; Beckett J; Lim CG
Pediatrics; 2013 May; 131(5):e1584-604. PubMed ID: 23545375
[TBL] [Abstract][Full Text] [Related]
11. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
13. Improving state Medicaid policies with comparative effectiveness research: a key role for academic health centers.
Zerzan JT; Gibson M; Libby AM
Acad Med; 2011 Jun; 86(6):695-700. PubMed ID: 21512359
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity.
Ray GT; Levine P; Croen LA; Bokhari FA; Hu TW; Habel LA
Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1063-9. PubMed ID: 17018466
[TBL] [Abstract][Full Text] [Related]
15. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
Pelham WE; Foster EM; Robb JA
J Pediatr Psychol; 2007 Jul; 32(6):711-27. PubMed ID: 17556402
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
17. Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison.
Sorenson C
Issue Brief (Commonw Fund); 2010 Jul; 91():1-14. PubMed ID: 20614655
[TBL] [Abstract][Full Text] [Related]
18. Attention-deficit/hyperactivity disorder: evidence-based diagnosis and management for primary care clinicians.
Liu YH; Stein MT
Minerva Pediatr; 2004 Dec; 56(6):567-83. PubMed ID: 15765020
[TBL] [Abstract][Full Text] [Related]
19. Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.
Denchev P; Kaltman JR; Schoenbaum M; Vitiello B
Circulation; 2010 Mar; 121(11):1329-37. PubMed ID: 20212277
[TBL] [Abstract][Full Text] [Related]
20. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
Pelham WE; Foster EM; Robb JA
Ambul Pediatr; 2007; 7(1 Suppl):121-31. PubMed ID: 17261491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
